Korea drugmakers focus on time release technology

Published: 2010-08-12 06:59:00

Updated: 2010-08-12 06:59:00

Domestic pharmaceutical companies have turned their eyes to time release technology that may ensure better prices of insurance-covered drugs and shorten a longer period of time in the development of new drugs.

Time release technology, also known as sustained-release (SR), sustained-action (SA)...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK